| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| von Willebrand Factor | 77 | 2024 | 676 | 7.500 |
Why?
|
| P-Selectin | 68 | 2018 | 599 | 5.310 |
Why?
|
| Neutrophils | 60 | 2024 | 3763 | 4.780 |
Why?
|
| Blood Platelets | 64 | 2020 | 2478 | 4.500 |
Why?
|
| Thrombosis | 44 | 2022 | 2942 | 3.560 |
Why?
|
| Venous Thrombosis | 19 | 2024 | 1303 | 3.070 |
Why?
|
| Platelet Adhesiveness | 20 | 2012 | 154 | 2.690 |
Why?
|
| Hydrolases | 9 | 2018 | 147 | 2.350 |
Why?
|
| ADAM Proteins | 14 | 2013 | 238 | 2.310 |
Why?
|
| Metalloendopeptidases | 12 | 2016 | 393 | 1.840 |
Why?
|
| Mice, Inbred C57BL | 101 | 2024 | 22117 | 1.830 |
Why?
|
| Mice, Knockout | 77 | 2024 | 14388 | 1.810 |
Why?
|
| Endothelium, Vascular | 49 | 2012 | 4433 | 1.790 |
Why?
|
| Platelet Glycoprotein GPIb-IX Complex | 15 | 2014 | 144 | 1.650 |
Why?
|
| Mice | 175 | 2024 | 81368 | 1.590 |
Why?
|
| Neutrophil Activation | 6 | 2021 | 180 | 1.470 |
Why?
|
| Leukocytes | 28 | 2013 | 2024 | 1.400 |
Why?
|
| Platelet Membrane Glycoproteins | 19 | 2004 | 284 | 1.400 |
Why?
|
| E-Selectin | 26 | 2011 | 577 | 1.310 |
Why?
|
| Histones | 14 | 2022 | 2577 | 1.290 |
Why?
|
| Animals | 215 | 2024 | 168202 | 1.280 |
Why?
|
| Inflammasomes | 6 | 2024 | 526 | 1.260 |
Why?
|
| Arthritis | 2 | 2023 | 680 | 1.140 |
Why?
|
| Blood-Brain Barrier | 9 | 2018 | 1027 | 1.130 |
Why?
|
| von Willebrand Diseases | 7 | 2013 | 132 | 1.120 |
Why?
|
| Thrombocytopenia | 9 | 2013 | 1182 | 1.110 |
Why?
|
| Carcinoma, Lewis Lung | 3 | 2018 | 108 | 1.010 |
Why?
|
| Platelet Activation | 21 | 2016 | 646 | 1.000 |
Why?
|
| Peritonitis | 9 | 2022 | 368 | 0.990 |
Why?
|
| Capillary Permeability | 8 | 2018 | 773 | 0.950 |
Why?
|
| Cell Adhesion Molecules | 15 | 2007 | 1602 | 0.920 |
Why?
|
| Fibronectins | 14 | 2007 | 723 | 0.890 |
Why?
|
| Leukotriene B4 | 2 | 2023 | 280 | 0.890 |
Why?
|
| Inflammation | 27 | 2024 | 10759 | 0.880 |
Why?
|
| Hemostasis | 13 | 2016 | 469 | 0.860 |
Why?
|
| Disease Models, Animal | 37 | 2024 | 18220 | 0.860 |
Why?
|
| Endothelium | 19 | 2007 | 764 | 0.840 |
Why?
|
| Arteriosclerosis | 9 | 2002 | 1056 | 0.840 |
Why?
|
| Platelet Aggregation | 13 | 2018 | 771 | 0.830 |
Why?
|
| Membrane Glycoproteins | 14 | 2016 | 3688 | 0.810 |
Why?
|
| Intercellular Adhesion Molecule-1 | 11 | 2018 | 1128 | 0.810 |
Why?
|
| Weibel-Palade Bodies | 7 | 2017 | 19 | 0.810 |
Why?
|
| Cell Adhesion | 36 | 2012 | 3088 | 0.790 |
Why?
|
| Chemotaxis | 2 | 2023 | 598 | 0.790 |
Why?
|
| Vena Cava, Inferior | 3 | 2020 | 458 | 0.770 |
Why?
|
| Arthritis, Experimental | 2 | 2022 | 291 | 0.760 |
Why?
|
| Interleukin-1beta | 2 | 2024 | 998 | 0.750 |
Why?
|
| Arterioles | 9 | 2008 | 250 | 0.730 |
Why?
|
| Guanine Nucleotide Exchange Factors | 6 | 2011 | 569 | 0.710 |
Why?
|
| Blood Coagulation | 15 | 2018 | 1154 | 0.700 |
Why?
|
| Fibrinogen | 6 | 2021 | 887 | 0.700 |
Why?
|
| DNA | 15 | 2020 | 7196 | 0.700 |
Why?
|
| Atherosclerosis | 5 | 2022 | 3400 | 0.690 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 4 | 2011 | 682 | 0.670 |
Why?
|
| Myocardial Reperfusion Injury | 2 | 2013 | 481 | 0.670 |
Why?
|
| Serotonin | 4 | 2013 | 1041 | 0.660 |
Why?
|
| Hemorrhage | 9 | 2012 | 3418 | 0.640 |
Why?
|
| Leukocyte Rolling | 7 | 2012 | 69 | 0.630 |
Why?
|
| Myocardium | 4 | 2024 | 4725 | 0.630 |
Why?
|
| Cytoplasmic Granules | 12 | 1999 | 573 | 0.590 |
Why?
|
| Chromatin | 7 | 2020 | 2955 | 0.590 |
Why?
|
| Hypoxia-Ischemia, Brain | 2 | 2013 | 353 | 0.580 |
Why?
|
| Venules | 10 | 2012 | 161 | 0.580 |
Why?
|
| Vasculitis | 3 | 2017 | 522 | 0.570 |
Why?
|
| Sirtuin 3 | 1 | 2017 | 67 | 0.570 |
Why?
|
| Integrins | 7 | 2011 | 834 | 0.560 |
Why?
|
| Calcium Signaling | 1 | 2021 | 734 | 0.540 |
Why?
|
| Thrombotic Microangiopathies | 2 | 2015 | 123 | 0.530 |
Why?
|
| Blood Vessels | 6 | 2010 | 1112 | 0.530 |
Why?
|
| Tryptophan Hydroxylase | 2 | 2013 | 94 | 0.520 |
Why?
|
| Integrin beta3 | 5 | 2007 | 120 | 0.520 |
Why?
|
| Apolipoproteins E | 5 | 2009 | 1443 | 0.510 |
Why?
|
| Factor VIII | 4 | 2010 | 348 | 0.510 |
Why?
|
| Vascular System Injuries | 1 | 2019 | 245 | 0.510 |
Why?
|
| Neutrophil Infiltration | 8 | 2019 | 390 | 0.510 |
Why?
|
| Endotoxemia | 2 | 2015 | 196 | 0.500 |
Why?
|
| Platelet Glycoprotein GPIIb-IIIa Complex | 5 | 2014 | 577 | 0.500 |
Why?
|
| Selectins | 6 | 1999 | 101 | 0.500 |
Why?
|
| Reactive Oxygen Species | 5 | 2017 | 2137 | 0.490 |
Why?
|
| Protein Precursors | 11 | 1994 | 1131 | 0.490 |
Why?
|
| Scavenger Receptors, Class B | 2 | 2012 | 85 | 0.480 |
Why?
|
| Mice, Inbred BALB C | 14 | 2019 | 6188 | 0.460 |
Why?
|
| Recombinant Proteins | 13 | 2018 | 6520 | 0.440 |
Why?
|
| Leukocyte-Adhesion Deficiency Syndrome | 3 | 2007 | 21 | 0.430 |
Why?
|
| Fibrinolytic Agents | 6 | 2017 | 2073 | 0.430 |
Why?
|
| Chemotaxis, Leukocyte | 6 | 2010 | 661 | 0.430 |
Why?
|
| Mice, Transgenic | 18 | 2019 | 9526 | 0.410 |
Why?
|
| Blood Preservation | 5 | 2011 | 169 | 0.410 |
Why?
|
| Myocardial Contraction | 1 | 2018 | 1515 | 0.410 |
Why?
|
| Endothelial Cells | 5 | 2022 | 3550 | 0.410 |
Why?
|
| Caspase 1 | 3 | 2022 | 226 | 0.400 |
Why?
|
| Immunity, Innate | 9 | 2022 | 3045 | 0.400 |
Why?
|
| Mice, Inbred DBA | 2 | 2023 | 619 | 0.390 |
Why?
|
| Cytoprotection | 1 | 2012 | 200 | 0.390 |
Why?
|
| Thromboplastin | 5 | 2012 | 286 | 0.390 |
Why?
|
| Blood Cells | 2 | 2008 | 305 | 0.380 |
Why?
|
| Collagen | 10 | 2022 | 2634 | 0.380 |
Why?
|
| Metalloproteases | 3 | 2011 | 61 | 0.370 |
Why?
|
| Apolipoprotein A-I | 1 | 2012 | 299 | 0.360 |
Why?
|
| Astrocytes | 1 | 2018 | 1341 | 0.360 |
Why?
|
| Mice, Mutant Strains | 12 | 2011 | 1748 | 0.360 |
Why?
|
| Purpura, Thrombotic Thrombocytopenic | 3 | 2007 | 131 | 0.350 |
Why?
|
| Deoxyribonuclease I | 4 | 2018 | 224 | 0.350 |
Why?
|
| Thrombin | 10 | 2016 | 592 | 0.350 |
Why?
|
| Blotting, Western | 9 | 2015 | 5034 | 0.350 |
Why?
|
| Ventricular Remodeling | 1 | 2018 | 1265 | 0.350 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 8 | 2012 | 3798 | 0.350 |
Why?
|
| Arthritis, Rheumatoid | 2 | 2023 | 3752 | 0.340 |
Why?
|
| X-Ray Microtomography | 2 | 2022 | 455 | 0.340 |
Why?
|
| Receptors, Serotonin, 5-HT2 | 1 | 2009 | 6 | 0.340 |
Why?
|
| Histamine | 5 | 2017 | 499 | 0.340 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 6 | 2009 | 691 | 0.330 |
Why?
|
| Umbilical Veins | 13 | 2005 | 426 | 0.330 |
Why?
|
| Cardiotonic Agents | 1 | 2012 | 539 | 0.330 |
Why?
|
| Wound Healing | 5 | 2015 | 2802 | 0.330 |
Why?
|
| Lung Diseases | 1 | 2019 | 1909 | 0.320 |
Why?
|
| Graft Survival | 1 | 2019 | 3814 | 0.320 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2015 | 1117 | 0.320 |
Why?
|
| Nucleosomes | 6 | 2018 | 487 | 0.310 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2013 | 634 | 0.310 |
Why?
|
| Male | 75 | 2024 | 360402 | 0.310 |
Why?
|
| Flow Cytometry | 11 | 2015 | 5863 | 0.310 |
Why?
|
| Vascular Endothelial Growth Factor A | 4 | 2015 | 3492 | 0.310 |
Why?
|
| Acute Lung Injury | 1 | 2012 | 367 | 0.310 |
Why?
|
| Peroxiredoxins | 1 | 2008 | 51 | 0.310 |
Why?
|
| Monocytes | 8 | 2016 | 2565 | 0.310 |
Why?
|
| Humans | 137 | 2024 | 760740 | 0.300 |
Why?
|
| Fibrosis | 4 | 2020 | 2047 | 0.300 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2011 | 506 | 0.300 |
Why?
|
| Ventricular Function, Left | 2 | 2018 | 3873 | 0.300 |
Why?
|
| Status Epilepticus | 1 | 2013 | 461 | 0.290 |
Why?
|
| Platelet Transfusion | 3 | 2009 | 298 | 0.290 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 4 | 2022 | 629 | 0.290 |
Why?
|
| Gait | 1 | 2013 | 811 | 0.290 |
Why?
|
| rap1 GTP-Binding Proteins | 5 | 2011 | 51 | 0.290 |
Why?
|
| HL-60 Cells | 6 | 2021 | 364 | 0.290 |
Why?
|
| Blood Coagulation Factors | 6 | 1985 | 366 | 0.290 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2012 | 687 | 0.290 |
Why?
|
| Citrulline | 3 | 2018 | 107 | 0.290 |
Why?
|
| Photochemistry | 1 | 2007 | 239 | 0.280 |
Why?
|
| Autoimmune Diseases | 1 | 2019 | 2238 | 0.280 |
Why?
|
| Veins | 3 | 2010 | 767 | 0.280 |
Why?
|
| Cells, Cultured | 36 | 2017 | 18937 | 0.280 |
Why?
|
| Thrombolytic Therapy | 2 | 2013 | 2055 | 0.270 |
Why?
|
| Erythrocytes | 2 | 2013 | 2410 | 0.270 |
Why?
|
| Heart Failure | 2 | 2023 | 11670 | 0.270 |
Why?
|
| Cystathionine beta-Synthase | 1 | 2005 | 27 | 0.260 |
Why?
|
| Solubility | 6 | 2018 | 1089 | 0.260 |
Why?
|
| Heart Ventricles | 1 | 2018 | 3796 | 0.250 |
Why?
|
| Brain Infarction | 1 | 2007 | 289 | 0.250 |
Why?
|
| Melanoma, Experimental | 1 | 2008 | 561 | 0.240 |
Why?
|
| Organelles | 3 | 1993 | 266 | 0.240 |
Why?
|
| Myocardial Infarction | 2 | 2024 | 11458 | 0.240 |
Why?
|
| Macrophage-1 Antigen | 5 | 2006 | 285 | 0.240 |
Why?
|
| Stroke | 4 | 2012 | 9715 | 0.240 |
Why?
|
| Cerebral Infarction | 2 | 2009 | 980 | 0.230 |
Why?
|
| L-Selectin | 6 | 2012 | 211 | 0.230 |
Why?
|
| CD40 Ligand | 2 | 2005 | 521 | 0.230 |
Why?
|
| Neoplasms | 7 | 2022 | 22131 | 0.230 |
Why?
|
| Cell Movement | 11 | 2009 | 5201 | 0.220 |
Why?
|
| Protein Structure, Tertiary | 8 | 2008 | 3793 | 0.220 |
Why?
|
| Cytoskeleton | 6 | 2020 | 1170 | 0.220 |
Why?
|
| Bone Marrow Transplantation | 7 | 2018 | 2690 | 0.220 |
Why?
|
| Prothrombin | 2 | 2016 | 190 | 0.220 |
Why?
|
| Paclitaxel | 1 | 2011 | 1730 | 0.210 |
Why?
|
| Splanchnic Circulation | 2 | 2006 | 119 | 0.210 |
Why?
|
| Macromolecular Substances | 15 | 1993 | 1433 | 0.210 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2012 | 1810 | 0.210 |
Why?
|
| Gene Expression Regulation | 7 | 2008 | 11874 | 0.210 |
Why?
|
| Disintegrins | 1 | 2022 | 27 | 0.210 |
Why?
|
| Brain Ischemia | 2 | 2016 | 3030 | 0.210 |
Why?
|
| Nuclear Envelope | 2 | 2020 | 162 | 0.210 |
Why?
|
| Ferric Compounds | 4 | 2012 | 378 | 0.200 |
Why?
|
| Lipopolysaccharides | 5 | 2015 | 2202 | 0.200 |
Why?
|
| Homocysteine | 1 | 2005 | 637 | 0.200 |
Why?
|
| Protein Processing, Post-Translational | 12 | 2011 | 1971 | 0.200 |
Why?
|
| Bleeding Time | 5 | 2006 | 83 | 0.200 |
Why?
|
| Plasminogen Inactivators | 1 | 2021 | 37 | 0.200 |
Why?
|
| Bernard-Soulier Syndrome | 1 | 2001 | 7 | 0.190 |
Why?
|
| Chlorides | 4 | 2012 | 665 | 0.190 |
Why?
|
| Crosses, Genetic | 3 | 2015 | 750 | 0.190 |
Why?
|
| Inflammation Mediators | 2 | 2019 | 1884 | 0.190 |
Why?
|
| Receptors, LDL | 3 | 2001 | 488 | 0.190 |
Why?
|
| Time Factors | 15 | 2018 | 39908 | 0.190 |
Why?
|
| Fluorescent Antibody Technique | 12 | 1998 | 2467 | 0.180 |
Why?
|
| Interleukin-11 | 1 | 2001 | 58 | 0.180 |
Why?
|
| Antigens, CD | 6 | 2007 | 3998 | 0.180 |
Why?
|
| Sepsis | 1 | 2015 | 2585 | 0.180 |
Why?
|
| Antigens | 5 | 2007 | 1441 | 0.180 |
Why?
|
| Dermatitis, Contact | 2 | 2005 | 133 | 0.180 |
Why?
|
| Interleukin-6 | 2 | 2022 | 3205 | 0.180 |
Why?
|
| Recombinant Fusion Proteins | 5 | 2015 | 3730 | 0.180 |
Why?
|
| Proto-Oncogene Proteins c-fos | 2 | 2000 | 584 | 0.180 |
Why?
|
| Fibrin | 6 | 2004 | 507 | 0.180 |
Why?
|
| Serine Proteinase Inhibitors | 1 | 2021 | 175 | 0.170 |
Why?
|
| Female | 55 | 2021 | 392203 | 0.170 |
Why?
|
| Refrigeration | 2 | 2011 | 27 | 0.170 |
Why?
|
| Transfection | 10 | 2012 | 5765 | 0.170 |
Why?
|
| Hemophilia A | 1 | 2003 | 359 | 0.170 |
Why?
|
| Fibrinolysis | 1 | 2021 | 331 | 0.170 |
Why?
|
| Extracellular Matrix | 6 | 2013 | 1718 | 0.170 |
Why?
|
| Ligands | 8 | 2007 | 3268 | 0.170 |
Why?
|
| Extracellular Space | 4 | 2014 | 562 | 0.170 |
Why?
|
| Carboxypeptidases | 1 | 1999 | 155 | 0.170 |
Why?
|
| Skin | 9 | 2012 | 4472 | 0.170 |
Why?
|
| Interferon-gamma | 1 | 2008 | 3145 | 0.160 |
Why?
|
| Hepatitis, Animal | 1 | 1998 | 19 | 0.160 |
Why?
|
| Aptamers, Nucleotide | 2 | 2012 | 164 | 0.160 |
Why?
|
| Hypothalamic Area, Lateral | 1 | 2000 | 108 | 0.160 |
Why?
|
| Molecular Weight | 13 | 1997 | 2185 | 0.160 |
Why?
|
| Cell Degranulation | 3 | 2017 | 277 | 0.160 |
Why?
|
| Cricetinae | 10 | 2012 | 2424 | 0.160 |
Why?
|
| Preoptic Area | 1 | 2000 | 132 | 0.160 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2010 | 2872 | 0.160 |
Why?
|
| Calcimycin | 7 | 2000 | 213 | 0.160 |
Why?
|
| Depression | 1 | 2018 | 8132 | 0.160 |
Why?
|
| Leukocytosis | 3 | 2012 | 251 | 0.160 |
Why?
|
| Antithrombins | 1 | 2021 | 292 | 0.160 |
Why?
|
| Transplantation, Homologous | 3 | 2019 | 4802 | 0.150 |
Why?
|
| Antifibrinolytic Agents | 1 | 2021 | 287 | 0.150 |
Why?
|
| Oxidative Stress | 1 | 2009 | 3115 | 0.150 |
Why?
|
| Fasting | 1 | 2004 | 1603 | 0.150 |
Why?
|
| Tumor Necrosis Factor-alpha | 5 | 2008 | 4340 | 0.150 |
Why?
|
| Embolism | 1 | 2001 | 399 | 0.150 |
Why?
|
| Receptors, Leukocyte-Adhesion | 1 | 1997 | 52 | 0.150 |
Why?
|
| Shwartzman Phenomenon | 3 | 2006 | 9 | 0.150 |
Why?
|
| Signal Transduction | 13 | 2018 | 23415 | 0.150 |
Why?
|
| Microscopy, Immunoelectron | 4 | 2000 | 317 | 0.140 |
Why?
|
| rac GTP-Binding Proteins | 1 | 2017 | 162 | 0.140 |
Why?
|
| p21-Activated Kinases | 1 | 2017 | 127 | 0.140 |
Why?
|
| Microscopy, Electron | 4 | 2009 | 2561 | 0.140 |
Why?
|
| Thromboembolism | 1 | 2003 | 991 | 0.140 |
Why?
|
| Membrane Proteins | 5 | 2007 | 7847 | 0.140 |
Why?
|
| Tissue Plasminogen Activator | 2 | 2012 | 1163 | 0.130 |
Why?
|
| Dose-Response Relationship, Drug | 7 | 2018 | 10754 | 0.130 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2019 | 540 | 0.130 |
Why?
|
| Evans Blue | 2 | 2006 | 42 | 0.130 |
Why?
|
| Endocytosis | 3 | 2012 | 955 | 0.130 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2005 | 2197 | 0.130 |
Why?
|
| Enzyme Precursors | 1 | 2016 | 170 | 0.130 |
Why?
|
| CHO Cells | 5 | 2012 | 1387 | 0.130 |
Why?
|
| Bone Marrow | 3 | 2007 | 2909 | 0.130 |
Why?
|
| Mice, Inbred Strains | 7 | 2008 | 1759 | 0.130 |
Why?
|
| Mast Cells | 3 | 2017 | 1392 | 0.130 |
Why?
|
| Lipid Metabolism | 1 | 2004 | 1896 | 0.130 |
Why?
|
| Cell Communication | 4 | 2012 | 1654 | 0.130 |
Why?
|
| Ionomycin | 1 | 2015 | 110 | 0.130 |
Why?
|
| Fibrinopeptide B | 3 | 1992 | 4 | 0.130 |
Why?
|
| Cell Membrane | 7 | 2020 | 3680 | 0.120 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 2 | 2016 | 558 | 0.120 |
Why?
|
| Phenotype | 9 | 2022 | 16572 | 0.120 |
Why?
|
| Adiposity | 1 | 2005 | 1879 | 0.120 |
Why?
|
| Tuberculosis | 1 | 2008 | 2015 | 0.120 |
Why?
|
| Transplantation Immunology | 2 | 2012 | 532 | 0.120 |
Why?
|
| Thioglycolates | 3 | 2005 | 37 | 0.120 |
Why?
|
| Carbonyl Cyanide m-Chlorophenyl Hydrazone | 2 | 2004 | 22 | 0.120 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 2 | 2018 | 426 | 0.120 |
Why?
|
| Microtubules | 4 | 2020 | 1073 | 0.110 |
Why?
|
| Neuropeptides | 1 | 2000 | 944 | 0.110 |
Why?
|
| alpha-Linolenic Acid | 1 | 2014 | 144 | 0.110 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2018 | 630 | 0.110 |
Why?
|
| Skin Window Technique | 2 | 2012 | 22 | 0.110 |
Why?
|
| Pilocarpine | 1 | 2013 | 64 | 0.110 |
Why?
|
| Enzyme Inhibitors | 3 | 2015 | 3705 | 0.110 |
Why?
|
| Megakaryocytes | 3 | 2007 | 566 | 0.110 |
Why?
|
| Orthomyxoviridae Infections | 1 | 2016 | 254 | 0.110 |
Why?
|
| Obesity | 3 | 2024 | 12934 | 0.110 |
Why?
|
| Microscopy | 2 | 2012 | 905 | 0.110 |
Why?
|
| Heterozygote | 3 | 2006 | 2780 | 0.110 |
Why?
|
| Peroxidase | 3 | 2012 | 610 | 0.110 |
Why?
|
| Arthus Reaction | 1 | 2012 | 14 | 0.110 |
Why?
|
| Liver | 5 | 2005 | 7512 | 0.110 |
Why?
|
| Acute Disease | 5 | 2012 | 7236 | 0.100 |
Why?
|
| Pulmonary Fibrosis | 1 | 2016 | 505 | 0.100 |
Why?
|
| Arterial Occlusive Diseases | 2 | 2008 | 748 | 0.100 |
Why?
|
| Brain | 6 | 2016 | 27100 | 0.100 |
Why?
|
| Biological Assay | 1 | 2015 | 626 | 0.100 |
Why?
|
| Meningitis | 3 | 2001 | 217 | 0.100 |
Why?
|
| Base Sequence | 10 | 2010 | 12420 | 0.100 |
Why?
|
| Up-Regulation | 4 | 2012 | 4117 | 0.100 |
Why?
|
| Influenza A virus | 1 | 2016 | 458 | 0.100 |
Why?
|
| Metabolome | 1 | 2019 | 988 | 0.100 |
Why?
|
| Afibrinogenemia | 2 | 2003 | 17 | 0.100 |
Why?
|
| Aptamers, Peptide | 1 | 2012 | 28 | 0.100 |
Why?
|
| Macrophages | 7 | 2009 | 5758 | 0.100 |
Why?
|
| Histological Techniques | 1 | 2012 | 194 | 0.100 |
Why?
|
| Hematopoietic Stem Cells | 3 | 1999 | 3394 | 0.100 |
Why?
|
| Microcirculation | 3 | 2014 | 1272 | 0.100 |
Why?
|
| Heme | 1 | 2014 | 313 | 0.100 |
Why?
|
| Mesenteric Veins | 3 | 2009 | 86 | 0.100 |
Why?
|
| Mesenteric Vascular Occlusion | 1 | 2012 | 92 | 0.100 |
Why?
|
| Cell Line | 12 | 2009 | 15577 | 0.100 |
Why?
|
| Myeloproliferative Disorders | 1 | 2018 | 611 | 0.100 |
Why?
|
| Coronary Circulation | 1 | 2018 | 1569 | 0.100 |
Why?
|
| Abortion, Spontaneous | 1 | 2016 | 532 | 0.100 |
Why?
|
| Benzimidazoles | 2 | 2015 | 858 | 0.100 |
Why?
|
| Carrier Proteins | 3 | 2004 | 4937 | 0.100 |
Why?
|
| Disulfides | 4 | 1989 | 464 | 0.090 |
Why?
|
| Neuraminidase | 1 | 2011 | 195 | 0.090 |
Why?
|
| Antibodies, Monoclonal | 10 | 2006 | 9171 | 0.090 |
Why?
|
| Reperfusion Injury | 3 | 2008 | 1023 | 0.090 |
Why?
|
| Cell Count | 2 | 2009 | 1834 | 0.090 |
Why?
|
| Hemoglobins | 2 | 2008 | 1524 | 0.090 |
Why?
|
| Carcinoma, Small Cell | 1 | 1993 | 420 | 0.090 |
Why?
|
| Bacterial Infections | 2 | 2016 | 1389 | 0.090 |
Why?
|
| Cell Fractionation | 4 | 1993 | 249 | 0.090 |
Why?
|
| Aging | 3 | 2006 | 8700 | 0.090 |
Why?
|
| Proteoglycans | 2 | 2006 | 803 | 0.090 |
Why?
|
| Growth Substances | 3 | 1998 | 768 | 0.090 |
Why?
|
| Troponin T | 1 | 2016 | 780 | 0.090 |
Why?
|
| Computer Systems | 1 | 2012 | 469 | 0.090 |
Why?
|
| Antigen-Antibody Complex | 1 | 2012 | 509 | 0.090 |
Why?
|
| Tight Junctions | 1 | 2013 | 324 | 0.090 |
Why?
|
| Adenosine Diphosphate | 3 | 2008 | 422 | 0.090 |
Why?
|
| Sinus of Valsalva | 2 | 2001 | 60 | 0.090 |
Why?
|
| Cricetulus | 1 | 2012 | 814 | 0.090 |
Why?
|
| Neovascularization, Physiologic | 1 | 1998 | 1349 | 0.090 |
Why?
|
| Insulin | 2 | 2004 | 6593 | 0.090 |
Why?
|
| Tissue Distribution | 3 | 2011 | 2261 | 0.090 |
Why?
|
| T-Lymphocytes | 1 | 2008 | 10175 | 0.090 |
Why?
|
| Neovascularization, Pathologic | 3 | 2009 | 2644 | 0.090 |
Why?
|
| Statistics, Nonparametric | 3 | 2012 | 2851 | 0.090 |
Why?
|
| Blood Donors | 1 | 2012 | 345 | 0.090 |
Why?
|
| Brain Injuries | 1 | 2001 | 2053 | 0.080 |
Why?
|
| Fluorescence | 1 | 2012 | 756 | 0.080 |
Why?
|
| Protein Binding | 7 | 2012 | 9345 | 0.080 |
Why?
|
| Molecular Sequence Data | 9 | 1996 | 17630 | 0.080 |
Why?
|
| Hemorheology | 3 | 2012 | 144 | 0.080 |
Why?
|
| Diet, Atherogenic | 2 | 2001 | 92 | 0.080 |
Why?
|
| Cell Death | 2 | 2018 | 1677 | 0.080 |
Why?
|
| Isoflurane | 1 | 2012 | 384 | 0.080 |
Why?
|
| Protein-Tyrosine Kinases | 2 | 2010 | 2425 | 0.080 |
Why?
|
| Receptors, IgG | 1 | 2012 | 558 | 0.080 |
Why?
|
| Cysteine | 2 | 2003 | 891 | 0.080 |
Why?
|
| Phospholipases A2 | 1 | 2009 | 197 | 0.080 |
Why?
|
| Aorta | 4 | 2003 | 2041 | 0.080 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2012 | 705 | 0.080 |
Why?
|
| Monensin | 2 | 1985 | 30 | 0.080 |
Why?
|
| Disease Progression | 5 | 2019 | 13495 | 0.080 |
Why?
|
| Memory | 1 | 2018 | 2192 | 0.080 |
Why?
|
| Fluoxetine | 1 | 2012 | 733 | 0.080 |
Why?
|
| Blood Circulation | 2 | 2012 | 248 | 0.080 |
Why?
|
| Motor Activity | 1 | 2018 | 2714 | 0.080 |
Why?
|
| Immunohistochemistry | 4 | 2011 | 11069 | 0.080 |
Why?
|
| Respiratory Tract Infections | 1 | 2016 | 1009 | 0.080 |
Why?
|
| Vascular Diseases | 1 | 1996 | 1159 | 0.080 |
Why?
|
| Shiga Toxins | 1 | 2007 | 40 | 0.080 |
Why?
|
| Cell Line, Tumor | 2 | 2018 | 16968 | 0.080 |
Why?
|
| Mesentery | 3 | 2008 | 202 | 0.070 |
Why?
|
| Receptors, Lipoprotein | 1 | 2008 | 88 | 0.070 |
Why?
|
| Angiopoietin-1 | 1 | 2008 | 122 | 0.070 |
Why?
|
| Complement C1 Inhibitor Protein | 1 | 2008 | 97 | 0.070 |
Why?
|
| Models, Biological | 5 | 2009 | 9461 | 0.070 |
Why?
|
| Bacteremia | 1 | 2015 | 977 | 0.070 |
Why?
|
| Leukotrienes | 1 | 2009 | 231 | 0.070 |
Why?
|
| DNA Primers | 4 | 2010 | 2817 | 0.070 |
Why?
|
| Antineoplastic Agents | 1 | 2011 | 13635 | 0.070 |
Why?
|
| Genotype | 4 | 2013 | 12977 | 0.070 |
Why?
|
| Cytokines | 7 | 2006 | 7373 | 0.070 |
Why?
|
| Complement Activation | 1 | 2009 | 445 | 0.070 |
Why?
|
| Anesthetics, Inhalation | 1 | 2012 | 572 | 0.070 |
Why?
|
| Medical Illustration | 1 | 2008 | 135 | 0.070 |
Why?
|
| Enzyme Activation | 2 | 2011 | 3591 | 0.070 |
Why?
|
| Graft Rejection | 2 | 2019 | 4438 | 0.070 |
Why?
|
| Glycoproteins | 3 | 2006 | 2200 | 0.070 |
Why?
|
| Tuberculin Test | 1 | 2008 | 206 | 0.070 |
Why?
|
| Receptors, Cell Surface | 3 | 2007 | 2802 | 0.070 |
Why?
|
| Amino Acids | 2 | 1992 | 1718 | 0.070 |
Why?
|
| Rats | 9 | 2012 | 23716 | 0.070 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2012 | 1333 | 0.070 |
Why?
|
| Immunoenzyme Techniques | 2 | 2008 | 1703 | 0.070 |
Why?
|
| Platelet Function Tests | 2 | 2012 | 271 | 0.070 |
Why?
|
| Leukocyte Elastase | 1 | 2007 | 114 | 0.070 |
Why?
|
| Antibodies, Blocking | 2 | 1997 | 243 | 0.070 |
Why?
|
| Cell Polarity | 1 | 2010 | 635 | 0.070 |
Why?
|
| Peptide Fragments | 6 | 1992 | 5109 | 0.070 |
Why?
|
| Pulmonary Embolism | 2 | 2012 | 2568 | 0.070 |
Why?
|
| Receptor, Adenosine A2B | 1 | 2006 | 34 | 0.070 |
Why?
|
| Semaphorins | 1 | 2007 | 96 | 0.070 |
Why?
|
| Hematopoiesis | 1 | 1996 | 2049 | 0.070 |
Why?
|
| Interleukin-4 Receptor alpha Subunit | 1 | 2006 | 57 | 0.070 |
Why?
|
| Hemodynamics | 4 | 2012 | 4160 | 0.070 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2018 | 1533 | 0.070 |
Why?
|
| Coronary Vessels | 1 | 2018 | 3095 | 0.070 |
Why?
|
| Microscopy, Video | 1 | 2006 | 241 | 0.070 |
Why?
|
| Pancreatic Elastase | 1 | 2006 | 127 | 0.070 |
Why?
|
| Cornea | 3 | 2006 | 1332 | 0.070 |
Why?
|
| Actins | 3 | 2010 | 2051 | 0.070 |
Why?
|
| Blood Glucose | 2 | 2015 | 6390 | 0.070 |
Why?
|
| Hematologic Neoplasms | 1 | 2018 | 1896 | 0.070 |
Why?
|
| Cryptosporidiosis | 1 | 2006 | 52 | 0.070 |
Why?
|
| Peptide Hydrolases | 3 | 2021 | 624 | 0.070 |
Why?
|
| Shock, Septic | 1 | 2012 | 769 | 0.070 |
Why?
|
| Stress, Mechanical | 2 | 2012 | 1674 | 0.070 |
Why?
|
| Age Factors | 2 | 2016 | 18381 | 0.060 |
Why?
|
| Haploidy | 1 | 2006 | 126 | 0.060 |
Why?
|
| Galactose | 1 | 2007 | 294 | 0.060 |
Why?
|
| Necrosis | 2 | 2008 | 1610 | 0.060 |
Why?
|
| Thrombopoiesis | 1 | 2007 | 164 | 0.060 |
Why?
|
| Homeostasis | 3 | 2009 | 3321 | 0.060 |
Why?
|
| Infusions, Intravenous | 1 | 2010 | 2214 | 0.060 |
Why?
|
| History, 19th Century | 1 | 2008 | 718 | 0.060 |
Why?
|
| Hydrogen Peroxide | 1 | 2009 | 730 | 0.060 |
Why?
|
| Shiga Toxin | 1 | 2005 | 36 | 0.060 |
Why?
|
| Dinitrofluorobenzene | 1 | 2005 | 17 | 0.060 |
Why?
|
| Embryonic Development | 1 | 2010 | 720 | 0.060 |
Why?
|
| Coagulants | 1 | 2005 | 45 | 0.060 |
Why?
|
| RNA Splicing | 1 | 1990 | 898 | 0.060 |
Why?
|
| Cell Migration Inhibition | 2 | 2005 | 97 | 0.060 |
Why?
|
| Anemia, Sickle Cell | 1 | 2014 | 1061 | 0.060 |
Why?
|
| Mannose-Binding Lectin | 1 | 2006 | 145 | 0.060 |
Why?
|
| Myocardial Ischemia | 1 | 2016 | 2110 | 0.060 |
Why?
|
| Neuroblastoma | 1 | 1993 | 1248 | 0.060 |
Why?
|
| Complement C1 Inactivator Proteins | 1 | 2005 | 89 | 0.060 |
Why?
|
| Hyperhomocysteinemia | 1 | 2005 | 118 | 0.060 |
Why?
|
| Vasodilation | 1 | 2009 | 962 | 0.060 |
Why?
|
| Austria | 2 | 2018 | 206 | 0.060 |
Why?
|
| Particle Size | 1 | 2009 | 1648 | 0.060 |
Why?
|
| Influenza, Human | 1 | 2016 | 1521 | 0.060 |
Why?
|
| Golgi Apparatus | 3 | 1994 | 404 | 0.060 |
Why?
|
| Hematology | 1 | 2008 | 243 | 0.060 |
Why?
|
| Radiation Chimera | 1 | 2004 | 215 | 0.060 |
Why?
|
| alpha 1-Antitrypsin | 1 | 2005 | 167 | 0.060 |
Why?
|
| Laminin | 1 | 2006 | 408 | 0.060 |
Why?
|
| Blood Coagulation Tests | 1 | 2005 | 271 | 0.060 |
Why?
|
| Globins | 1 | 2005 | 405 | 0.060 |
Why?
|
| Cold Temperature | 3 | 2004 | 785 | 0.060 |
Why?
|
| Furosemide | 1 | 2005 | 170 | 0.060 |
Why?
|
| Exocytosis | 2 | 2003 | 320 | 0.060 |
Why?
|
| Furans | 1 | 1985 | 202 | 0.060 |
Why?
|
| omega-N-Methylarginine | 1 | 2003 | 108 | 0.060 |
Why?
|
| Calorimetry, Indirect | 1 | 2004 | 174 | 0.060 |
Why?
|
| Transcription Factors | 4 | 2003 | 12116 | 0.060 |
Why?
|
| Kinetics | 6 | 2008 | 6370 | 0.060 |
Why?
|
| Second Messenger Systems | 1 | 2004 | 202 | 0.060 |
Why?
|
| Arteriovenous Fistula | 1 | 2007 | 319 | 0.060 |
Why?
|
| Anxiety | 1 | 2018 | 4573 | 0.060 |
Why?
|
| src-Family Kinases | 1 | 2006 | 535 | 0.060 |
Why?
|
| Phagocytosis | 2 | 2007 | 1526 | 0.050 |
Why?
|
| Ammonium Chloride | 3 | 1989 | 72 | 0.050 |
Why?
|
| Protein Kinase C | 1 | 2008 | 1202 | 0.050 |
Why?
|
| Lipoproteins, HDL | 1 | 2008 | 675 | 0.050 |
Why?
|
| Tubulin | 2 | 2003 | 692 | 0.050 |
Why?
|
| Tumor Cells, Cultured | 3 | 1998 | 6126 | 0.050 |
Why?
|
| Cholesterol | 3 | 2008 | 2902 | 0.050 |
Why?
|
| Diagnostic Imaging | 1 | 2017 | 3527 | 0.050 |
Why?
|
| Arteries | 2 | 2009 | 1120 | 0.050 |
Why?
|
| Wakefulness | 2 | 2000 | 1264 | 0.050 |
Why?
|
| Transforming Growth Factor beta | 2 | 2009 | 1962 | 0.050 |
Why?
|
| Genome-Wide Association Study | 1 | 2022 | 12661 | 0.050 |
Why?
|
| Enzymes | 1 | 2004 | 257 | 0.050 |
Why?
|
| Restriction Mapping | 3 | 1992 | 851 | 0.050 |
Why?
|
| Antibodies | 3 | 2006 | 2413 | 0.050 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2008 | 823 | 0.050 |
Why?
|
| Glycosylation | 3 | 2011 | 1098 | 0.050 |
Why?
|
| Gene Expression | 4 | 2000 | 7569 | 0.050 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 3 | 1992 | 1738 | 0.050 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2004 | 393 | 0.050 |
Why?
|
| Oxidation-Reduction | 3 | 2004 | 2231 | 0.050 |
Why?
|
| MAP Kinase Signaling System | 1 | 2009 | 1483 | 0.050 |
Why?
|
| Multiprotein Complexes | 2 | 2007 | 1118 | 0.050 |
Why?
|
| Platelet Aggregation Inhibitors | 2 | 2012 | 2746 | 0.050 |
Why?
|
| Dipeptides | 1 | 2004 | 391 | 0.050 |
Why?
|
| Transgenes | 1 | 2006 | 1008 | 0.050 |
Why?
|
| Leukemia, Myeloid | 1 | 1985 | 693 | 0.050 |
Why?
|
| Introns | 1 | 2005 | 968 | 0.050 |
Why?
|
| Young Adult | 3 | 2019 | 59191 | 0.050 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2012 | 6473 | 0.050 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2003 | 517 | 0.050 |
Why?
|
| Swine | 4 | 2012 | 5908 | 0.050 |
Why?
|
| Fluorescein-5-isothiocyanate | 1 | 2002 | 222 | 0.050 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2004 | 380 | 0.050 |
Why?
|
| Mutation, Missense | 1 | 2011 | 2570 | 0.050 |
Why?
|
| Bone Marrow Cells | 3 | 2006 | 2409 | 0.050 |
Why?
|
| Hydroxamic Acids | 1 | 2004 | 481 | 0.050 |
Why?
|
| Serine Endopeptidases | 1 | 1987 | 1022 | 0.050 |
Why?
|
| Dietary Supplements | 1 | 2014 | 3412 | 0.050 |
Why?
|
| Alleles | 4 | 2016 | 6861 | 0.050 |
Why?
|
| Hydrogen-Ion Concentration | 3 | 1994 | 2495 | 0.050 |
Why?
|
| Morpholines | 1 | 2004 | 581 | 0.050 |
Why?
|
| Salmonella | 1 | 2001 | 125 | 0.050 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2003 | 581 | 0.050 |
Why?
|
| Echocardiography | 1 | 2013 | 4987 | 0.050 |
Why?
|
| Chronic Disease | 2 | 2024 | 9310 | 0.050 |
Why?
|
| Cell Size | 1 | 2003 | 624 | 0.050 |
Why?
|
| Ionophores | 1 | 2000 | 107 | 0.050 |
Why?
|
| Drug Delivery Systems | 1 | 2012 | 2222 | 0.050 |
Why?
|
| Alternative Splicing | 1 | 2006 | 1088 | 0.050 |
Why?
|
| Vesicular Transport Proteins | 1 | 2003 | 376 | 0.050 |
Why?
|
| Blood Coagulation Disorders | 1 | 2004 | 350 | 0.050 |
Why?
|
| Trypsin | 3 | 1992 | 495 | 0.040 |
Why?
|
| Nitric Oxide Synthase | 1 | 2003 | 908 | 0.040 |
Why?
|
| Nanoparticles | 1 | 2012 | 1957 | 0.040 |
Why?
|
| Microscopy, Atomic Force | 1 | 2021 | 253 | 0.040 |
Why?
|
| Tunicamycin | 3 | 1992 | 108 | 0.040 |
Why?
|
| Calcium | 3 | 2015 | 5717 | 0.040 |
Why?
|
| Neurons | 1 | 2000 | 9436 | 0.040 |
Why?
|
| Antioxidants | 1 | 2008 | 1669 | 0.040 |
Why?
|
| Genes, fos | 1 | 2000 | 175 | 0.040 |
Why?
|
| Carboxypeptidase H | 1 | 1999 | 9 | 0.040 |
Why?
|
| Cell Compartmentation | 4 | 1989 | 384 | 0.040 |
Why?
|
| Corneal Neovascularization | 1 | 2002 | 185 | 0.040 |
Why?
|
| Cell Transformation, Viral | 1 | 1981 | 526 | 0.040 |
Why?
|
| Receptor, Insulin | 1 | 2004 | 836 | 0.040 |
Why?
|
| Nerve Tissue Proteins | 2 | 2010 | 4408 | 0.040 |
Why?
|
| History, 20th Century | 1 | 2008 | 2764 | 0.040 |
Why?
|
| Immunoglobulins | 1 | 2003 | 850 | 0.040 |
Why?
|
| Sequence Homology, Nucleic Acid | 2 | 1992 | 1058 | 0.040 |
Why?
|
| Galanin | 1 | 2000 | 42 | 0.040 |
Why?
|
| Fibroblast Growth Factors | 1 | 2006 | 865 | 0.040 |
Why?
|
| Cytosol | 2 | 2020 | 886 | 0.040 |
Why?
|
| Brain Edema | 1 | 2004 | 604 | 0.040 |
Why?
|
| Drug Combinations | 1 | 2006 | 2048 | 0.040 |
Why?
|
| Electrocardiography | 1 | 2013 | 6346 | 0.040 |
Why?
|
| Protein Transport | 1 | 2005 | 1966 | 0.040 |
Why?
|
| Umbilical Cord | 1 | 2001 | 177 | 0.040 |
Why?
|
| Remission Induction | 2 | 2018 | 2391 | 0.040 |
Why?
|
| Blood Cell Count | 2 | 2014 | 397 | 0.040 |
Why?
|
| Intestines | 1 | 2008 | 1909 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 5 | 2017 | 17878 | 0.040 |
Why?
|
| Chemotactic Factors, Eosinophil | 1 | 1999 | 40 | 0.040 |
Why?
|
| Cesium Radioisotopes | 1 | 1998 | 38 | 0.040 |
Why?
|
| Cerebellum | 1 | 2006 | 1501 | 0.040 |
Why?
|
| Thrombelastography | 1 | 2021 | 187 | 0.040 |
Why?
|
| Embryo, Mammalian | 2 | 2016 | 1670 | 0.040 |
Why?
|
| Fibroblast Growth Factor 2 | 2 | 1998 | 592 | 0.040 |
Why?
|
| Complement C3 | 3 | 2008 | 434 | 0.040 |
Why?
|
| Fish Oils | 1 | 2002 | 483 | 0.040 |
Why?
|
| Amino Acid Sequence | 5 | 1994 | 13442 | 0.040 |
Why?
|
| Case-Control Studies | 5 | 2018 | 22153 | 0.040 |
Why?
|
| Leukocyte Count | 2 | 2009 | 1597 | 0.040 |
Why?
|
| Drug Resistance, Microbial | 1 | 2001 | 825 | 0.040 |
Why?
|
| Severity of Illness Index | 3 | 2013 | 15829 | 0.040 |
Why?
|
| Borrelia burgdorferi Group | 1 | 1998 | 97 | 0.040 |
Why?
|
| Meat | 1 | 2001 | 584 | 0.040 |
Why?
|
| Colony-Forming Units Assay | 1 | 1998 | 351 | 0.040 |
Why?
|
| Macaca fascicularis | 2 | 2012 | 900 | 0.040 |
Why?
|
| Cats | 1 | 2000 | 974 | 0.040 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2002 | 699 | 0.040 |
Why?
|
| Cell Proliferation | 2 | 2018 | 10429 | 0.040 |
Why?
|
| Lung | 4 | 2014 | 9999 | 0.040 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2003 | 1692 | 0.040 |
Why?
|
| Chimera | 2 | 2003 | 453 | 0.040 |
Why?
|
| Platelet Count | 1 | 2001 | 780 | 0.040 |
Why?
|
| Simplexvirus | 1 | 1981 | 802 | 0.040 |
Why?
|
| Phosphorylation | 1 | 2009 | 8311 | 0.040 |
Why?
|
| Electromyography | 2 | 2000 | 1392 | 0.040 |
Why?
|
| Intracellular Fluid | 1 | 1998 | 201 | 0.040 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2002 | 858 | 0.040 |
Why?
|
| Chemokines, CC | 1 | 1999 | 283 | 0.040 |
Why?
|
| Aged | 8 | 2019 | 169092 | 0.040 |
Why?
|
| Selenoprotein P | 1 | 2017 | 33 | 0.040 |
Why?
|
| Endoplasmic Reticulum | 3 | 1991 | 1132 | 0.040 |
Why?
|
| Periodontal Diseases | 1 | 2001 | 451 | 0.040 |
Why?
|
| Complement Pathway, Alternative | 1 | 1997 | 113 | 0.040 |
Why?
|
| Hepatocytes | 1 | 2004 | 1231 | 0.040 |
Why?
|
| STAT Transcription Factors | 1 | 2018 | 188 | 0.040 |
Why?
|
| Granulation Tissue | 1 | 1997 | 92 | 0.040 |
Why?
|
| Embolization, Therapeutic | 1 | 2007 | 1418 | 0.040 |
Why?
|
| Eosinophils | 2 | 1999 | 953 | 0.040 |
Why?
|
| Splenectomy | 1 | 1998 | 389 | 0.030 |
Why?
|
| Insulin-Like Growth Factor Binding Proteins | 1 | 1998 | 208 | 0.030 |
Why?
|
| Perches | 1 | 1996 | 27 | 0.030 |
Why?
|
| Janus Kinases | 1 | 2018 | 248 | 0.030 |
Why?
|
| Apyrase | 1 | 1999 | 373 | 0.030 |
Why?
|
| Radiography | 1 | 2008 | 6961 | 0.030 |
Why?
|
| Clot Retraction | 1 | 2016 | 13 | 0.030 |
Why?
|
| Circadian Rhythm | 2 | 2000 | 2569 | 0.030 |
Why?
|
| Binding Sites | 2 | 2003 | 6051 | 0.030 |
Why?
|
| Crotalid Venoms | 1 | 2016 | 28 | 0.030 |
Why?
|
| Pneumonia, Aspiration | 1 | 1997 | 145 | 0.030 |
Why?
|
| Cholesterol, Dietary | 1 | 1997 | 224 | 0.030 |
Why?
|
| Lung Neoplasms | 2 | 2008 | 13383 | 0.030 |
Why?
|
| Ligation | 1 | 2017 | 446 | 0.030 |
Why?
|
| Keratinocytes | 2 | 1998 | 790 | 0.030 |
Why?
|
| Cardiovascular Diseases | 2 | 2017 | 15498 | 0.030 |
Why?
|
| Caspases, Initiator | 1 | 2016 | 31 | 0.030 |
Why?
|
| Cattle | 3 | 2002 | 3841 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 1 | 2015 | 7403 | 0.030 |
Why?
|
| Hypersensitivity, Delayed | 1 | 1997 | 490 | 0.030 |
Why?
|
| Middle Aged | 10 | 2018 | 220603 | 0.030 |
Why?
|
| Dermatitis | 1 | 1998 | 202 | 0.030 |
Why?
|
| Platelet Membrane Glycoprotein IIb | 2 | 2007 | 51 | 0.030 |
Why?
|
| Tunica Intima | 1 | 2018 | 458 | 0.030 |
Why?
|
| Breath Tests | 1 | 1997 | 299 | 0.030 |
Why?
|
| Microscopy, Phase-Contrast | 1 | 1995 | 110 | 0.030 |
Why?
|
| Ethylmaleimide | 2 | 1989 | 70 | 0.030 |
Why?
|
| Transcription Factor RelB | 1 | 1995 | 28 | 0.030 |
Why?
|
| Hirudins | 2 | 2006 | 179 | 0.030 |
Why?
|
| Oxazolone | 1 | 1995 | 61 | 0.030 |
Why?
|
| Proteomics | 1 | 2009 | 3836 | 0.030 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2005 | 2270 | 0.030 |
Why?
|
| Phenylalanine | 1 | 1997 | 365 | 0.030 |
Why?
|
| Species Specificity | 1 | 2000 | 2410 | 0.030 |
Why?
|
| Disease Susceptibility | 2 | 2016 | 1788 | 0.030 |
Why?
|
| Aortic Diseases | 1 | 2001 | 735 | 0.030 |
Why?
|
| Splenomegaly | 1 | 1996 | 190 | 0.030 |
Why?
|
| Adult | 10 | 2016 | 220995 | 0.030 |
Why?
|
| Renal Dialysis | 1 | 2005 | 1795 | 0.030 |
Why?
|
| Adenosine Triphosphatases | 1 | 1999 | 835 | 0.030 |
Why?
|
| Biological Transport | 1 | 1999 | 2089 | 0.030 |
Why?
|
| Electrodes, Implanted | 1 | 2000 | 838 | 0.030 |
Why?
|
| Lipoproteins, LDL | 1 | 1998 | 642 | 0.030 |
Why?
|
| Transplantation | 1 | 1996 | 219 | 0.030 |
Why?
|
| Sulfonamides | 1 | 2005 | 1977 | 0.030 |
Why?
|
| Retinal Rod Photoreceptor Cells | 1 | 1996 | 204 | 0.030 |
Why?
|
| Toll-Like Receptor 7 | 1 | 2016 | 165 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 1 | 2008 | 5493 | 0.030 |
Why?
|
| Adoptive Transfer | 1 | 2017 | 818 | 0.030 |
Why?
|
| Auditory Pathways | 1 | 1997 | 237 | 0.030 |
Why?
|
| Arthritis, Infectious | 1 | 1998 | 347 | 0.030 |
Why?
|
| Dogs | 1 | 1999 | 3837 | 0.030 |
Why?
|
| Janus Kinase 2 | 1 | 2018 | 560 | 0.030 |
Why?
|
| Genetic Engineering | 2 | 1999 | 931 | 0.030 |
Why?
|
| Nitric Oxide | 1 | 2003 | 2135 | 0.030 |
Why?
|
| Ulcer | 1 | 1996 | 203 | 0.030 |
Why?
|
| Mutagenesis | 1 | 1998 | 1230 | 0.030 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 1999 | 1434 | 0.030 |
Why?
|
| Carotid Arteries | 1 | 1999 | 941 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 3 | 2010 | 6074 | 0.030 |
Why?
|
| HEK293 Cells | 2 | 2015 | 4269 | 0.030 |
Why?
|
| Sleep | 2 | 2000 | 4764 | 0.030 |
Why?
|
| Glomerulonephritis | 1 | 1996 | 331 | 0.030 |
Why?
|
| Interferon-beta | 1 | 2016 | 345 | 0.030 |
Why?
|
| Cytoplasm | 1 | 1998 | 1503 | 0.030 |
Why?
|
| Molecular Biology | 1 | 1997 | 575 | 0.030 |
Why?
|
| Heparin | 1 | 2001 | 1632 | 0.030 |
Why?
|
| Osteomyelitis | 1 | 2018 | 407 | 0.030 |
Why?
|
| Diet | 2 | 2005 | 8049 | 0.030 |
Why?
|
| Ischemic Attack, Transient | 1 | 1999 | 874 | 0.030 |
Why?
|
| Rosette Formation | 1 | 1993 | 152 | 0.030 |
Why?
|
| Aspirin | 1 | 2005 | 3127 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2005 | 5780 | 0.030 |
Why?
|
| Chromatography, Affinity | 2 | 1992 | 532 | 0.030 |
Why?
|
| Coronary Artery Disease | 1 | 2013 | 6403 | 0.030 |
Why?
|
| Substrate Specificity | 2 | 2015 | 1790 | 0.030 |
Why?
|
| Binding, Competitive | 1 | 2015 | 1141 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2017 | 727 | 0.030 |
Why?
|
| Neutropenia | 1 | 1998 | 885 | 0.030 |
Why?
|
| Matrix Metalloproteinases | 2 | 2006 | 391 | 0.030 |
Why?
|
| Lipoxins | 1 | 1996 | 419 | 0.030 |
Why?
|
| Cell Culture Techniques | 1 | 2001 | 1662 | 0.030 |
Why?
|
| Sulfates | 1 | 1994 | 379 | 0.030 |
Why?
|
| Caspases | 1 | 2016 | 878 | 0.030 |
Why?
|
| Muscle, Smooth | 1 | 1997 | 927 | 0.030 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2002 | 1390 | 0.030 |
Why?
|
| Nitriles | 1 | 2018 | 971 | 0.030 |
Why?
|
| Genes, Plant | 1 | 1992 | 128 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2008 | 14649 | 0.030 |
Why?
|
| Latex | 2 | 1982 | 49 | 0.030 |
Why?
|
| Visual Pathways | 1 | 1997 | 551 | 0.030 |
Why?
|
| Integrin beta Chains | 1 | 2012 | 115 | 0.030 |
Why?
|
| Acute Kidney Injury | 1 | 2005 | 1923 | 0.030 |
Why?
|
| Factor XII | 1 | 2012 | 19 | 0.030 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 1999 | 1348 | 0.030 |
Why?
|
| 8-Bromo Cyclic Adenosine Monophosphate | 1 | 1992 | 73 | 0.030 |
Why?
|
| Complement Pathway, Classical | 2 | 2005 | 91 | 0.020 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 1979 | 2821 | 0.020 |
Why?
|
| Lipoproteins | 1 | 1997 | 879 | 0.020 |
Why?
|
| Quebec | 1 | 2012 | 140 | 0.020 |
Why?
|
| Mesenteric Arteries | 1 | 2012 | 178 | 0.020 |
Why?
|
| Mass Screening | 1 | 2008 | 5425 | 0.020 |
Why?
|
| Gene Deletion | 1 | 1999 | 2659 | 0.020 |
Why?
|
| Stem Cells | 2 | 1996 | 3514 | 0.020 |
Why?
|
| Genes, Regulator | 1 | 1992 | 373 | 0.020 |
Why?
|
| GTP-Binding Protein alpha Subunit, Gi2 | 1 | 2011 | 34 | 0.020 |
Why?
|
| Immunoglobulin E | 1 | 1998 | 1502 | 0.020 |
Why?
|
| Leukemia, Promyelocytic, Acute | 1 | 1993 | 251 | 0.020 |
Why?
|
| Carotid Artery Diseases | 1 | 2018 | 877 | 0.020 |
Why?
|
| Drug Stability | 1 | 2012 | 291 | 0.020 |
Why?
|
| Pertussis Toxin | 1 | 2011 | 176 | 0.020 |
Why?
|
| Cell Nucleus | 1 | 2020 | 2894 | 0.020 |
Why?
|
| tat Gene Products, Human Immunodeficiency Virus | 1 | 2011 | 119 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2006 | 5074 | 0.020 |
Why?
|
| Precipitin Tests | 1 | 1992 | 813 | 0.020 |
Why?
|
| Biological Availability | 1 | 2012 | 389 | 0.020 |
Why?
|
| Class Ib Phosphatidylinositol 3-Kinase | 1 | 2011 | 42 | 0.020 |
Why?
|
| Fibrinopeptide A | 2 | 1989 | 43 | 0.020 |
Why?
|
| Autoradiography | 1 | 1992 | 728 | 0.020 |
Why?
|
| Phospholipase C gamma | 1 | 2011 | 131 | 0.020 |
Why?
|
| GPI-Linked Proteins | 1 | 2012 | 469 | 0.020 |
Why?
|
| Epitopes | 1 | 1997 | 2501 | 0.020 |
Why?
|
| Polyglycolic Acid | 1 | 2012 | 406 | 0.020 |
Why?
|
| Intracranial Thrombosis | 1 | 2011 | 108 | 0.020 |
Why?
|
| Half-Life | 1 | 2012 | 650 | 0.020 |
Why?
|
| Protein C | 1 | 2011 | 133 | 0.020 |
Why?
|
| Biomimetic Materials | 1 | 2012 | 172 | 0.020 |
Why?
|
| Transendothelial and Transepithelial Migration | 1 | 2011 | 100 | 0.020 |
Why?
|
| Organoids | 2 | 1987 | 744 | 0.020 |
Why?
|
| Mutation | 4 | 1997 | 30015 | 0.020 |
Why?
|
| Zinc Fingers | 1 | 1992 | 578 | 0.020 |
Why?
|
| Injections, Subcutaneous | 1 | 2012 | 671 | 0.020 |
Why?
|
| Thrombocytosis | 1 | 2010 | 88 | 0.020 |
Why?
|
| Ovalbumin | 1 | 1992 | 675 | 0.020 |
Why?
|
| Mitochondria | 1 | 2003 | 3619 | 0.020 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 1992 | 618 | 0.020 |
Why?
|
| Lymphocyte Function-Associated Antigen-1 | 1 | 2011 | 378 | 0.020 |
Why?
|
| Pregnancy | 5 | 2016 | 29869 | 0.020 |
Why?
|
| Injections, Intravenous | 1 | 2012 | 1376 | 0.020 |
Why?
|
| Phosphotyrosine | 1 | 2010 | 456 | 0.020 |
Why?
|
| Phospholipids | 1 | 1993 | 787 | 0.020 |
Why?
|
| Glycine | 1 | 1993 | 661 | 0.020 |
Why?
|
| Small Molecule Libraries | 1 | 2015 | 733 | 0.020 |
Why?
|
| Arabidopsis | 1 | 1992 | 465 | 0.020 |
Why?
|
| Arginine | 1 | 1993 | 933 | 0.020 |
Why?
|
| Dopamine | 1 | 1996 | 1606 | 0.020 |
Why?
|
| Protein Conformation | 2 | 1987 | 3965 | 0.020 |
Why?
|
| Triglycerides | 1 | 1997 | 2459 | 0.020 |
Why?
|
| Dietary Fats | 1 | 1997 | 1995 | 0.020 |
Why?
|
| Specimen Handling | 1 | 1993 | 701 | 0.020 |
Why?
|
| Receptor, Bradykinin B2 | 1 | 2008 | 24 | 0.020 |
Why?
|
| Chromosome Deletion | 1 | 1993 | 1386 | 0.020 |
Why?
|
| Fibroblasts | 4 | 1987 | 4140 | 0.020 |
Why?
|
| Lymphocytes | 1 | 1996 | 2604 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2000 | 8165 | 0.020 |
Why?
|
| Models, Anatomic | 1 | 2012 | 683 | 0.020 |
Why?
|
| Insulin-Like Growth Factor I | 3 | 2004 | 1932 | 0.020 |
Why?
|
| Lipids | 1 | 2019 | 3332 | 0.020 |
Why?
|
| Liver Diseases | 1 | 1997 | 1297 | 0.020 |
Why?
|
| RNA, Messenger | 3 | 2000 | 12759 | 0.020 |
Why?
|
| Protein Engineering | 1 | 1992 | 548 | 0.020 |
Why?
|
| GTP-Binding Proteins | 1 | 1992 | 949 | 0.020 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gi-Go | 1 | 2008 | 89 | 0.020 |
Why?
|
| DNA-Binding Proteins | 3 | 2004 | 9586 | 0.020 |
Why?
|
| Receptors, Thrombin | 1 | 2008 | 130 | 0.020 |
Why?
|
| Cell Aggregation | 1 | 2008 | 239 | 0.020 |
Why?
|
| Amino Acid Motifs | 1 | 2010 | 927 | 0.020 |
Why?
|
| Lumicolchicines | 1 | 1987 | 3 | 0.020 |
Why?
|
| Structure-Activity Relationship | 2 | 1986 | 3074 | 0.020 |
Why?
|
| Antigens, Differentiation | 1 | 1990 | 908 | 0.020 |
Why?
|
| Pyrazoles | 1 | 2018 | 2008 | 0.020 |
Why?
|
| Nocodazole | 1 | 1987 | 95 | 0.020 |
Why?
|
| Down-Regulation | 2 | 2005 | 2916 | 0.020 |
Why?
|
| Electroencephalography | 2 | 2000 | 6240 | 0.020 |
Why?
|
| Placenta | 1 | 2016 | 1709 | 0.020 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2008 | 411 | 0.020 |
Why?
|
| Popliteal Vein | 1 | 2007 | 43 | 0.020 |
Why?
|
| Cloning, Molecular | 2 | 1992 | 4172 | 0.020 |
Why?
|
| Lysosomes | 1 | 1993 | 925 | 0.020 |
Why?
|
| Interleukin-3 | 1 | 2008 | 425 | 0.020 |
Why?
|
| Shear Strength | 1 | 2007 | 160 | 0.020 |
Why?
|
| Lactic Acid | 1 | 2012 | 1139 | 0.020 |
Why?
|
| Ischemia | 1 | 1995 | 1885 | 0.020 |
Why?
|
| Viral Load | 1 | 2016 | 3325 | 0.020 |
Why?
|
| Mannosyl-Glycoprotein Endo-beta-N-Acetylglucosaminidase | 1 | 1986 | 20 | 0.020 |
Why?
|
| NF-kappa B | 1 | 1995 | 2481 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2011 | 1739 | 0.020 |
Why?
|
| Acetylglucosaminidase | 1 | 1986 | 66 | 0.020 |
Why?
|
| Prospective Studies | 4 | 2018 | 54364 | 0.020 |
Why?
|
| Body Patterning | 1 | 2010 | 632 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 1993 | 2639 | 0.020 |
Why?
|
| Interleukin-1 | 2 | 2001 | 1248 | 0.020 |
Why?
|
| Peptides | 2 | 2004 | 4354 | 0.020 |
Why?
|
| Swainsonine | 1 | 1985 | 9 | 0.020 |
Why?
|
| Microfluidic Analytical Techniques | 1 | 2012 | 799 | 0.020 |
Why?
|
| Cell Shape | 1 | 2007 | 369 | 0.020 |
Why?
|
| Microscopy, Fluorescence, Multiphoton | 1 | 2007 | 267 | 0.020 |
Why?
|
| Pyrimidines | 1 | 2018 | 3027 | 0.020 |
Why?
|
| Colchicine | 1 | 1987 | 259 | 0.020 |
Why?
|
| Risk | 1 | 2018 | 9603 | 0.020 |
Why?
|
| Aged, 80 and over | 3 | 2016 | 58919 | 0.020 |
Why?
|
| Plasmids | 1 | 1991 | 2265 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2016 | 2896 | 0.020 |
Why?
|
| Rats, Inbred Lew | 2 | 1997 | 1157 | 0.020 |
Why?
|
| Nucleic Acid Conformation | 1 | 2009 | 901 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2016 | 4910 | 0.020 |
Why?
|
| Biotinylation | 1 | 2005 | 184 | 0.020 |
Why?
|
| Popliteal Artery | 1 | 2007 | 310 | 0.020 |
Why?
|
| Microbodies | 1 | 1984 | 36 | 0.010 |
Why?
|
| Luminescent Proteins | 1 | 2007 | 836 | 0.010 |
Why?
|
| Venous Thromboembolism | 1 | 2018 | 1866 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2015 | 5433 | 0.010 |
Why?
|
| Survival Rate | 1 | 1998 | 12719 | 0.010 |
Why?
|
| Molecular Structure | 1 | 1989 | 1878 | 0.010 |
Why?
|
| Autoimmunity | 1 | 2012 | 1350 | 0.010 |
Why?
|
| 2,2'-Dipyridyl | 1 | 1984 | 9 | 0.010 |
Why?
|
| Haiti | 1 | 2006 | 550 | 0.010 |
Why?
|
| N-Ethylmaleimide-Sensitive Proteins | 1 | 2003 | 9 | 0.010 |
Why?
|
| Alkaloids | 1 | 1985 | 192 | 0.010 |
Why?
|
| Saphenous Vein | 1 | 2007 | 516 | 0.010 |
Why?
|
| Diglycerides | 1 | 2004 | 177 | 0.010 |
Why?
|
| Electric Stimulation | 1 | 2009 | 1734 | 0.010 |
Why?
|
| Carcinoembryonic Antigen | 1 | 2005 | 335 | 0.010 |
Why?
|
| Subcellular Fractions | 1 | 1984 | 531 | 0.010 |
Why?
|
| Vascular Patency | 1 | 2007 | 911 | 0.010 |
Why?
|
| SNARE Proteins | 1 | 2003 | 80 | 0.010 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 2005 | 361 | 0.010 |
Why?
|
| Microbial Collagenase | 1 | 1984 | 112 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2016 | 10072 | 0.010 |
Why?
|
| RNA | 1 | 1993 | 2713 | 0.010 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 1993 | 1405 | 0.010 |
Why?
|
| NG-Nitroarginine Methyl Ester | 1 | 2003 | 260 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2018 | 12448 | 0.010 |
Why?
|
| Erythroid-Specific DNA-Binding Factors | 1 | 2003 | 195 | 0.010 |
Why?
|
| Immunoprecipitation | 1 | 2005 | 876 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2018 | 11118 | 0.010 |
Why?
|
| Adjuvants, Immunologic | 1 | 2008 | 990 | 0.010 |
Why?
|
| Sex Factors | 1 | 1997 | 10549 | 0.010 |
Why?
|
| Fluoroimmunoassay | 1 | 2002 | 30 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2007 | 1697 | 0.010 |
Why?
|
| Femoral Artery | 1 | 2007 | 826 | 0.010 |
Why?
|
| Cell Survival | 2 | 2003 | 5780 | 0.010 |
Why?
|
| Oligopeptides | 1 | 2008 | 1185 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 1995 | 4512 | 0.010 |
Why?
|
| Kidney Function Tests | 1 | 2005 | 677 | 0.010 |
Why?
|
| Kupffer Cells | 1 | 2003 | 143 | 0.010 |
Why?
|
| Syndecans | 1 | 2002 | 75 | 0.010 |
Why?
|
| Concanavalin A | 1 | 2002 | 190 | 0.010 |
Why?
|
| Temperature | 1 | 1989 | 2224 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 2006 | 1525 | 0.010 |
Why?
|
| Turkeys | 1 | 2001 | 44 | 0.010 |
Why?
|
| Cephalosporin Resistance | 1 | 2001 | 17 | 0.010 |
Why?
|
| GATA1 Transcription Factor | 1 | 2003 | 296 | 0.010 |
Why?
|
| Feasibility Studies | 2 | 2007 | 5239 | 0.010 |
Why?
|
| Electrophoresis, Gel, Pulsed-Field | 1 | 2001 | 141 | 0.010 |
Why?
|
| District of Columbia | 1 | 2001 | 159 | 0.010 |
Why?
|
| Salmonella enterica | 1 | 2001 | 76 | 0.010 |
Why?
|
| Syndecan-1 | 1 | 2002 | 163 | 0.010 |
Why?
|
| Cross-Sectional Studies | 2 | 2013 | 26065 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2008 | 4569 | 0.010 |
Why?
|
| Staining and Labeling | 1 | 1985 | 1081 | 0.010 |
Why?
|
| Serotyping | 1 | 2001 | 325 | 0.010 |
Why?
|
| Single-Blind Method | 1 | 2005 | 1575 | 0.010 |
Why?
|
| Risk Factors | 3 | 2017 | 74128 | 0.010 |
Why?
|
| Ceftriaxone | 1 | 2001 | 175 | 0.010 |
Why?
|
| Drug Resistance, Multiple | 1 | 2001 | 255 | 0.010 |
Why?
|
| Glycopeptides | 1 | 1981 | 220 | 0.010 |
Why?
|
| Mitochondrial Diseases | 1 | 2004 | 343 | 0.010 |
Why?
|
| Microscopy, Confocal | 1 | 2006 | 1970 | 0.010 |
Why?
|
| Cyanides | 1 | 1980 | 82 | 0.010 |
Why?
|
| Iodoacetates | 1 | 1979 | 19 | 0.010 |
Why?
|
| Receptors, Purinergic P2Y1 | 1 | 1999 | 40 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 1993 | 7583 | 0.010 |
Why?
|
| Incidence | 1 | 2018 | 21339 | 0.010 |
Why?
|
| Chickens | 1 | 2001 | 858 | 0.010 |
Why?
|
| Probability | 1 | 2005 | 2475 | 0.010 |
Why?
|
| Chemokine CCL11 | 1 | 1999 | 128 | 0.010 |
Why?
|
| Hypersensitivity | 1 | 2008 | 1167 | 0.010 |
Why?
|
| Rhodamine 123 | 1 | 1998 | 37 | 0.010 |
Why?
|
| Boston | 1 | 2012 | 9313 | 0.010 |
Why?
|
| Receptors, Lymphocyte Homing | 1 | 1999 | 141 | 0.010 |
Why?
|
| Integrin alpha4beta1 | 1 | 1999 | 119 | 0.010 |
Why?
|
| Light | 2 | 1996 | 1352 | 0.010 |
Why?
|
| Gingiva | 1 | 2001 | 410 | 0.010 |
Why?
|
| Microspheres | 1 | 1982 | 782 | 0.010 |
Why?
|
| Passive Cutaneous Anaphylaxis | 1 | 1998 | 31 | 0.010 |
Why?
|
| Zymosan | 1 | 1998 | 134 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2005 | 3410 | 0.010 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2002 | 561 | 0.010 |
Why?
|
| Receptors, Purinergic P2 | 1 | 1999 | 150 | 0.010 |
Why?
|
| Mice, Inbred CBA | 1 | 1999 | 436 | 0.010 |
Why?
|
| Follow-Up Studies | 2 | 2013 | 39062 | 0.010 |
Why?
|
| Rhodamines | 1 | 1998 | 178 | 0.010 |
Why?
|
| Exudates and Transudates | 1 | 1998 | 174 | 0.010 |
Why?
|
| Alveolar Bone Loss | 1 | 2001 | 390 | 0.010 |
Why?
|
| Sulfhydryl Compounds | 1 | 1979 | 301 | 0.010 |
Why?
|
| Complement Inactivator Proteins | 1 | 1997 | 74 | 0.010 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 1 | 1 | 1998 | 127 | 0.010 |
Why?
|
| Reference Values | 1 | 2005 | 4919 | 0.010 |
Why?
|
| Transcription Factor Brn-3 | 1 | 1997 | 3 | 0.010 |
Why?
|
| Transcription Factor Brn-3B | 1 | 1997 | 4 | 0.010 |
Why?
|
| Intestinal Mucosa | 1 | 2008 | 3031 | 0.010 |
Why?
|
| Transcription Factor Brn-3A | 1 | 1997 | 13 | 0.010 |
Why?
|
| Virulence | 1 | 2001 | 1299 | 0.010 |
Why?
|
| Mice, Inbred C3H | 1 | 1998 | 913 | 0.010 |
Why?
|
| Body Temperature | 1 | 2000 | 780 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2013 | 15250 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2005 | 4845 | 0.010 |
Why?
|
| Darkness | 1 | 1996 | 158 | 0.010 |
Why?
|
| Lipoxygenase | 1 | 1996 | 72 | 0.010 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 1 | 1998 | 416 | 0.010 |
Why?
|
| Hybridomas | 1 | 1997 | 442 | 0.010 |
Why?
|
| Liposomes | 2 | 1990 | 784 | 0.010 |
Why?
|
| Retinal Vessels | 1 | 2002 | 853 | 0.010 |
Why?
|
| Gene Targeting | 1 | 1999 | 837 | 0.010 |
Why?
|
| Periodontitis | 1 | 2001 | 568 | 0.010 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2001 | 637 | 0.010 |
Why?
|
| Back | 1 | 1995 | 64 | 0.010 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 1998 | 618 | 0.010 |
Why?
|
| Liver Function Tests | 1 | 1997 | 524 | 0.010 |
Why?
|
| Hydroxyeicosatetraenoic Acids | 1 | 1996 | 224 | 0.010 |
Why?
|
| Epidermal Growth Factor | 1 | 1998 | 699 | 0.010 |
Why?
|
| Basement Membrane | 1 | 1996 | 349 | 0.010 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2001 | 1936 | 0.010 |
Why?
|
| Pulmonary Alveoli | 1 | 1997 | 652 | 0.010 |
Why?
|
| Nervous System Malformations | 1 | 1997 | 244 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 2001 | 2358 | 0.010 |
Why?
|
| Ankle Joint | 1 | 1998 | 446 | 0.010 |
Why?
|
| Eicosanoids | 1 | 1996 | 282 | 0.010 |
Why?
|
| Bacterial Proteins | 1 | 2007 | 3842 | 0.010 |
Why?
|
| Heart Transplantation | 2 | 1999 | 3233 | 0.010 |
Why?
|
| Skull | 1 | 1998 | 818 | 0.010 |
Why?
|
| Immunization, Passive | 1 | 1996 | 616 | 0.010 |
Why?
|
| Kidney Glomerulus | 1 | 1996 | 568 | 0.010 |
Why?
|
| Epithelium | 1 | 1998 | 1603 | 0.010 |
Why?
|
| Sleep Deprivation | 1 | 2000 | 847 | 0.010 |
Why?
|
| Cerebrospinal Fluid | 1 | 1996 | 544 | 0.010 |
Why?
|
| Proteinuria | 1 | 1996 | 605 | 0.010 |
Why?
|
| Somatosensory Cortex | 1 | 1997 | 512 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2005 | 8516 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2001 | 6223 | 0.010 |
Why?
|
| Organ Preservation | 1 | 1996 | 382 | 0.010 |
Why?
|
| Consensus Sequence | 1 | 1992 | 364 | 0.010 |
Why?
|
| Sialic Acids | 1 | 1992 | 123 | 0.010 |
Why?
|
| Carbohydrate Sequence | 1 | 1992 | 411 | 0.010 |
Why?
|
| Frontal Lobe | 1 | 1998 | 1418 | 0.010 |
Why?
|
| Prognosis | 1 | 2012 | 29601 | 0.010 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1992 | 704 | 0.010 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 1992 | 944 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 1998 | 1901 | 0.010 |
Why?
|
| Thrombophlebitis | 1 | 1991 | 289 | 0.010 |
Why?
|
| Bacteria | 1 | 2001 | 2192 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2013 | 20556 | 0.010 |
Why?
|
| Intracellular Membranes | 1 | 1991 | 389 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2012 | 41464 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2007 | 64572 | 0.010 |
Why?
|
| Phylogeny | 1 | 1997 | 2805 | 0.010 |
Why?
|
| Papio | 1 | 1991 | 669 | 0.000 |
Why?
|
| Sequence Alignment | 1 | 1992 | 2178 | 0.000 |
Why?
|
| Gene Library | 1 | 1990 | 1055 | 0.000 |
Why?
|
| Blotting, Northern | 1 | 1989 | 1545 | 0.000 |
Why?
|
| Retina | 1 | 1996 | 2655 | 0.000 |
Why?
|
| Infant | 1 | 2006 | 36157 | 0.000 |
Why?
|
| Adolescent | 1 | 2012 | 88247 | 0.000 |
Why?
|
| Proteins | 1 | 1998 | 6030 | 0.000 |
Why?
|
| Risk Assessment | 1 | 2005 | 23974 | 0.000 |
Why?
|
| Reproducibility of Results | 1 | 2001 | 20077 | 0.000 |
Why?
|
| Blood Proteins | 1 | 1986 | 1172 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2007 | 36401 | 0.000 |
Why?
|
| Chemistry | 1 | 1978 | 346 | 0.000 |
Why?
|
| Chemical Phenomena | 1 | 1978 | 506 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 2007 | 80583 | 0.000 |
Why?
|
| Cell Differentiation | 1 | 1992 | 11512 | 0.000 |
Why?
|